Introduction
The detection of susceptibility genes for complex traits has attracted much interest in human genetics. There is growing interest in the use of single-nucleotide polymorphisms (SNPs) for the analysis of complex human diseases Kruglyak 1999) . For complex diseases, genomewide association studies using SNPs have been suggested as more appropriate for detection of susceptibility genes than genome-wide linkage analyses (Risch and Merikangas 1996; Lander 1996; Morton and Collins 1998; Risch and Teng 1998) . The study of genome-wide associations in complex traits requires a large sample size because the expected effect of each gene is small and extremely low significance levels need to be adopted (Risch 2000; Ohashi and Tokunaga 2001) . Actually, however, in addition to the large sample size required, the cost of genotyping is frequently one of the most important considerations. If the total budget for genotyping is limited, it is very important to choose the optimal study design for the budget available (Amos and Page 2001; Gu and Rao 2001) . In the present study, we introduce a stepwise focusing method to reduce the total cost of genotyping. By this method, the candidate markers are selected in a stepwise fashion. We evaluated the validity of the stepwise focusing method under several conditions by using Monte Carlo simulations. We then searched for the optimal conditions for the stepwise focusing method when the total numbers of both typings and markers to be examined were fixed.
Methods

Models
We consider the case in which only one biallelic marker is associated with a disease (denoted a disease-associated locus). A disease-associated locus is assumed to consist of two alleles, A and a, the former being positively associated with the disease. Let k be the probability that an individual with the genotype aa develops the disease, and r the genotype relative risk, so that the probability that an individual with the genotype Aa develops the disease is kr (0 Ͻ k Ͻ 1, r Ն 1). We assume that the probability that an individual with genotype AA exhibits the disease is kr m (m Ն 1). Then, the prevalence of the disease in the population will be
where p A is the frequency of allele A in the population. We assume Hardy-Weinberg equilibrium (HWE) in the population. By Bayes' theorem, the probabilities that affected individuals have the AA, Aa, or aa genotypes will be Pr( 
respectively.
Statistical tests
In population-based case-control studies, the aim is to detect those alleles more frequently observed in the cases than in the control groups. Generally, the statistical test used in association-based case-control study design is the 2 test for independence to detect significant intergroup differences (e.g., Sasieni 1997) . We assume biallelic (SNP) markers and have employed the 2 test without Yates' correction by using 2 ϫ 2 allele number tables (df ϭ 1) to characterize marker-disease associations. In the present study, we assume no population stratification. When the numbers of allele A and a among n affected individuals are N A and N a , respectively, and the numbers of alleles A and a among n unaffected individuals are M A and M a , respectively, then
Stepwise focusing method
The stepwise focusing method comprises two (or more) steps. In the first focusing step, the samples from both case and control groups are genotyped at a certain number of SNP markers, and the markers that exhibit significant intergroup differences with the 2 test using 2 ϫ 2 allele number tables at a relatively high significance level α (for example, α ϭ 0.1) are selected. This means that most of the markers selected in the first step are likely to be false positives. In the second step, the markers selected in the first step are tested by using a different set of case-control samples. In the second step, a larger number of individuals and a lower α value are used for marker selection. For example, suppose we carry out a case-control study using 50 000 SNP markers and the criterion for the selection of markers is α ϭ 0.1 in the first step; then, the average number of false-positive markers selected in the first step will be 5000. If those 5000 markers are tested at α ϭ 0.0001 in the second step, then, on average, less than one false-positive marker will be selected.
Simulations and power calculations
To calculate the power to detect disease susceptibility alleles with the stepwise focusing method compared with that using the conventional method, we performed extensive simulations. First, we calculated the expected frequencies of alleles A and a in the case and control groups [Pr(A | Affected) and Pr(a | Affected), and Pr(A | Unaffected) and Pr(a | Unaffected), respectively] with various values of r, p A , k, and m in the population. Second, we sampled n 1 affected and n 1 unaffected individuals by using a Monte Carlo simulation according to the probabilities of A and a alleles in each population assuming HWE.
2 tests for independence were then performed on the simulated samples. We repeated these tests 10 000 times, and the proportion of tests in which the null hypothesis (no association) was rejected was determined.
Results and discussion
Power of the stepwise focusing method When we set the parameter values to k ϭ 0.03, r ϭ 2, m ϭ 1, and p A ϭ 0.3, then we obtained K ϭ 0.045, Pr(A | Affected) ϭ 0.40, Pr(a | Affected) ϭ 0.60, Pr(A | Unaffected) ϭ 0.30, and Pr(a | Unaffected) ϭ 0.70. The first step of focusing was simulated by randomly selecting the alleles from both affected and unaffected populations according to the probabilities described above. Thus, if the number of subjects in each population was 250 (n 1 ϭ 250), we selected either allele A or a according to the probabilities described above for 250 affected subjects and 250 unaffected subjects, assuming HWE. The number of allele A should follow the binomial distribution for each of the two groups. We then made a 2 ϫ 2 table, each cell of which contained the number of either allele A or allele a. The rows of the table corresponded to affected and unaffected groups, and the columns corresponded to alleles A and a. We then calculated the sample 2 value from the data in the table. This simulation (sampling of the alleles and calculating the 2 value) was repeated 10 000 times, and the results showed that 0.90 of all sampling attempts resulted in 2 values of more than 3.84, which is the threshold 2 value at α ϭ 0.05. The relationship between the number of affected individuals examined and the power is shown in Fig. 1 . Thus, with the parameters assigned as above, about 90% of the diseaseassociated markers can be expected to be selected in the first step. However, when markers with 2 values larger than this threshold are selected, an average of 5% of all markers selected will not be related to the disease. Therefore, if 50 000 markers not associated with the disease are tested, the expected number of false-positive markers will be 2500. In the stepwise focusing method, the 2500 markers selected in the first step are subjected to the second focusing step by using a different set of samples consisting of a certain number (n 2 ) of affected and unaffected individuals.
If n 2 is 550, and the results are analyzed equivalently by using the 2 test for independence with α ϭ 0.0001 as the significance level, then the expected number of falsepositive markers will be 2500 ϫ 0.0001 ϭ 0.25. The Monte Carlo simulation performed as in the first step revealed that 0.89 of the positive markers would be selected. Therefore, the probability that a positive marker will be selected through the two steps is 0.9 ϫ 0.89 Ӎ 0.80. Thus, if the population parameters are as stated above, the numbers of each group for the first and second steps are 250 and 550, respectively, and the thresholds for selection of the first and second steps are 2 values at α ϭ 0.05 and α ϭ 0.0001, respectively, the expected overall false-positive rate and power will be 0.000005 and 0.80, respectively. If 50 000 markers are examined, the risk of excluding the null hypothesis of independence will be 50 000 ϫ 0.000005 ϭ 0.25 considering Bonferroni's correction for multiple testing. The total number of genotypings necessary for this study will be 50 000 ϫ 500 ϩ 2500 ϫ 1100 ϭ 27 750 000.
How many genotypings are needed to obtain a similar type I error rate and power if the number of focusing steps is only one? For the expected type I error rate to be 0.000005, the threshold 2 value at α ϭ 0.000005 is required for the first (and only) step. The number of affected (and unaffected) individuals required to obtain a power of 0.80 with the parameters given above will be 635 (according to a Monte Carlo simulation as described above). In this case, the total number of typings required will be 50 000 ϫ 1270 ϭ 63 500 000, which is much larger than that required with the stepwise focusing method (27 750 000 typings, as stated above). Alternatively, we can fix both the total number of genotypings and the overall type I error rate, and observe differences in the power. If the total number of typings is 27 750 000, the number of affected (and unaffected) indi- Fig. 1 . Relationship between numbers of affected individuals examined and power. Parameters were p A ϭ 0.3, k ϭ 0.03, and m ϭ 1, and r as shown in the figure, where p A denotes the frequency of allele A in the population, k is the probability of disease for a subject with genotype aa, and m and r are parameters such that the probabilities of the disease for the subjects with the genotypes Aa and aa are kr and kr m , respectively. The probabilities of alleles A and a in affected and unaffected individuals were calculated from the above parameters, and the numbers of affected and unaffected individuals shown were simulated. The simulation was repeated 10 000 times, and the proportion of repeats with significant differences (with varying α value) is shown as the power viduals whose genes can be typed will be 277, and the power will be 0.15. Therefore, a much higher power can be attained with the stepwise focusing method than with the conventional method.
Optimization of study design using the stepwise focusing method
We searched for the optimal conditions for the stepwise focusing method when the total numbers of both genotypings and markers to be examined were fixed. These conditions are realistic for genome-wide linkage disequilibrium (LD) analyses using high-throughput typing systems. In such studies, the total number of typings limits the study because it affects the total cost most strikingly. Let N T be the total number of typings allowed and N M be the number of markers examined, and let the number of affected subjects examined in the first step be n 1 . Then, the total number of typings in the first step will be 2N M n 1 , and the number of typings for the second step will be N T Ϫ 2N M n 1 . If the number of affected subjects examined in the second step is n 2 , then the upper limit of the number of markers examined in the second step will be (N T Ϫ 2N M n 1 )/n 2 . Figure 2 shows the relationship between the total number of samples and the power of the stepwise focusing method when the population parameters are fixed at p A ϭ 0.3, k ϭ 0.03, and m ϭ 1. The threshold 2 value for the first focusing step was fixed at α ϭ 0.1. Therefore, the expected number of false-positive Fig. 2 . Overall power in detecting association between a marker and the disease by the stepwise focusing method. The relationship between the number of subjects in each sample (affected and unaffected) in the first (n 1 ) and second (n 2 ) steps and the overall power. The total number of genotypings and the number of markers examined were set at 30 000 000 and 50 000, respectively. The fixed values (p A ϭ 0.3, k ϭ 0.03, and m ϭ 1) were as in Fig. 1 . The simulation was performed for two r values. The significance value in the first focusing step was set at 0.1, and, therefore, the expected number of false-positive markers after the first step was 5000. The significance value in the second step was varied from 0.1 to 0.00001, and the expected number of falsepositive markers at each significance value is shown in the right panel. The left panels show the overall power under various conditions markers at the first step will be 5000. If we can collect 750 affected (and unaffected) individuals, and set the numbers of each group for the first and second steps at 250 and 500, respectively, the expected number of false-positive markers and overall power will be 0.5 and 0.79, respectively for r ϭ 2 and an α value of the second focusing step of 0.0001. If we can collect 1200 affected (and unaffected) individuals, we can attain an overall power of 0.92, as the expected number of false-positive markers is 0.5.
The relationship between n 1 , n 2 , and the overall power under several values of p A and k is shown in Fig. 3 . The overall power is higher when the probability of disease for a subject with genotype aa is large. When the frequency of the susceptible allele in the population is small, the power is much lower, even if the stepwise focusing method is adopted.
In addition to the numbers of genotypings and markers, the number of affected (and unaffected) individuals is sometimes limited. Figure 4 shows the relationship between the significance value at the first and second steps, n 1 , n 2 , and the overall power when the total number of subjects in the affected and unaffected sample (n 1 ϩ n 2 ) and the total number of genotypings are limited. The optimal number of subjects to be selected at the first and second steps varies depending on the value to which the significance level at the first step is set. In the case shown in Fig. 4 , we can attain an overall power of 0.91 (the highest under such conditions) when we set the numbers of each group for the first and second steps at 200 and 800, respectively, and set the significance value at the first step at 0.1. Almost the same Fig. 3 . Relationship between n 1 , n 2 , and the overall power for several values of p A and k. The total number of genotypings and the number of markers examined were set at 30 000 000 and 50 000, respectively. The population parameters were set to r ϭ 2 and m ϭ 1. The significance value in the first step was set at 0.1 Fig. 4 . Relationship between the significance value at the first and second steps, n 1 , n 2 , and the overall power when the total number of subjects in the affected and unaffected sample (n 1 ϩ n 2 ) and the total number of genotypings are limited. n 1 ϩ n 2 was fixed at 1000 and the total number of genotypings was fixed at 30 000 000. The number of markers examined was set at 50 000. The population parameters were set to r ϭ 2, p A ϭ 0.3, k ϭ 0.03, and m ϭ 1. The significance values at the first and second steps were set so that the expected number of falsepositive markers was less than 1. Results are plotted only for possible combinations in which the total number of genotypings is under 30 000 000 power can be attained when n 1 ϭ 250, n 2 ϭ 750, and the significance value at the first step is set at 0.05. The total numbers of typings necessary in each case are 28 000 000 and 28 750 000, respectively. Thus, we can determine the optimal values for the significance value at the first step, n 1 , and n 2 under limited conditions using the stepwise focusing method.
In the present study, we used a Monte Carlo simulation method to infer alpha and beta statistics. To calculate the statistical power or required sample sizes, a classical equation using normal distribution is often applied. However, when one of the ratios (the expected frequencies of allele A and a in the case and control groups) in the 2 ϫ 2 tables to test is too small (for example, when p A ϭ 0.01 in Fig. 3) , it cannot be assumed that the difference in the two ratios follows a normal distribution. The Monte Carlo simulation method enables us to calculate almost exact statistical power or required sample sizes even in such cases. In almost all cases examined in this study (except for p A ϭ 0.01), the calculation results from the Monte Carlo simulation and from the classical equation are in good agreement (data not shown).
Thus, the stepwise focusing method presented here may be very useful for attaining a much higher power when a study is limited by the total cost of genotyping. By using the stepwise focusing method, the optimal study design given the total budget for genotyping can be estimated.
